Real-world analysis finds surgery improves prognosis in elderly ovarian cancer patients, suggesting gaps in gene testing and treatment access.
Our real-world study demonstrates that just a small number of elderly patients with ovarian cancer received standard treatment and gene testing during treatment;those patients who accepted surgery, standardized treatment and maintenance had a better PFS and OS; the prognosis is even worse for patients who are older than 71;surgery and maintenance treatment are identified as independent prognostic factors for PFS, whereas surgery alone emerged as an independent prognostic factor for OS.While these findings provide valuable insights, it is important to note that this was a single-center retrospective analysis, and further validation in larger, prospective cohorts is warranted.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: